Suzhou-based Bioventure Investment Management Ltd and Tianjin based Tasly Great Health Industry Fund have led a RMB100 million ($14.5 million) series B round into Zhejiang-based Zhejiang POCTech Medical Corp, that helps manage diabetes, the China Money Network reported.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
